German antitrust authorities have blocked Asklepios’s previously-cleared acquisition of more than 10 percent in rival hospital cooperation Rhoen-Klinikum after finding Asklepios failed to meet concessions originally agreed upon for the deal. Reports say Germany’s Federal Cartel Office agreed in March to allow the buyout that would see 10.1 percent of Rhoen in control of Asklepios as long as Asklepios sold a hospital and medical center in one region. Since, the cooperative has reportedly not met those conditions; Rhoen told media that the watchdog has now blocked the buyout.
Featured News
SEC Enforcement Chief Margaret Ryan Steps Down After Six Months
Mar 16, 2026 by
CPI
India’s CCI Prepares Action on Potential Anti-Competitive Conduct in AI Sector
Mar 16, 2026 by
CPI
Proposal Calls for Treating Digital Platform Design Standards Like Physical Infrastructure
Mar 16, 2026 by
CPI
Europe’s Cybersecurity Clock Is Ticking. Here’s What Companies Need to Know
Mar 16, 2026 by
CPI
European Publishers and Startups Call for Swift EU Decision in Google Case
Mar 16, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece